The University of Chicago Header Logo

Connection

Anita Chong to Graft Survival

Back to Details
This is a "connection" page, showing publications Anita Chong has written about Graft Survival.
Anita Chong
Connection Strength
5.214
Graft Survival
  1. Outstanding questions in transplantation: B cells, alloantibodies, and humoral rejection. Am J Transplant. 2019 08; 19(8):2155-2163.
    View in: PubMed
    Score: 0.459
  2. Evolving Approaches in the Identification of Allograft-Reactive T and B Cells in Mice and Humans. Transplantation. 2017 11; 101(11):2671-2681.
    View in: PubMed
    Score: 0.416
  3. Erosion of Transplantation Tolerance After Infection. Am J Transplant. 2017 01; 17(1):81-90.
    View in: PubMed
    Score: 0.380
  4. Cutting Edge: CTLA-4Ig Inhibits Memory B Cell Responses and Promotes Allograft Survival in Sensitized Recipients. J Immunol. 2015 Nov 01; 195(9):4069-73.
    View in: PubMed
    Score: 0.359
  5. New kid on the pretransplant block: IgG recognizing apoptotic cells. Am J Transplant. 2014 Jul; 14(7):1477-8.
    View in: PubMed
    Score: 0.329
  6. Making a B-line for transplantation tolerance. Am J Transplant. 2011 Mar; 11(3):420-1.
    View in: PubMed
    Score: 0.261
  7. Antagonistic effect of toll-like receptor signaling and bacterial infections on transplantation tolerance. Transplantation. 2009 May 15; 87(9 Suppl):S77-9.
    View in: PubMed
    Score: 0.231
  8. Toll-like receptor signaling in transplantation. Curr Opin Organ Transplant. 2008 Aug; 13(4):358-65.
    View in: PubMed
    Score: 0.219
  9. CAR Treg synergy with anti-CD154 promotes infectious tolerance and dictates allogeneic heart transplant acceptance. JCI Insight. 2025 Apr 08; 10(7).
    View in: PubMed
    Score: 0.174
  10. Sex and gender as predictors for allograft and patient-relevant outcomes after kidney transplantation. Cochrane Database Syst Rev. 2024 12 19; 12:CD014966.
    View in: PubMed
    Score: 0.170
  11. Update on the immunological mechanisms of primary graft dysfunction and chronic lung allograft dysfunction. Curr Opin Organ Transplant. 2024 Dec 01; 29(6):412-419.
    View in: PubMed
    Score: 0.168
  12. Reduced Satb1 expression predisposes CD4+ T conventional cells to Treg suppression and promotes transplant survival. Proc Natl Acad Sci U S A. 2022 10 04; 119(40):e2205062119.
    View in: PubMed
    Score: 0.146
  13. CTLA-41g in combination with anti-CD40L prolongs xenograft survival and inhibits anti-gal ab production in GT-Ko mice. Am J Transplant. 2002 Jan; 2(1):41-7.
    View in: PubMed
    Score: 0.139
  14. Non-depleting anti-CD4, but not anti-CD8, antibody induces long-term survival of xenogeneic and allogeneic hearts in alpha1,3-galactosyltransferase knockout (GT-Ko) mice. Xenotransplantation. 2000 Nov; 7(4):275-83.
    View in: PubMed
    Score: 0.128
  15. Resilience of T cell-intrinsic dysfunction in transplantation tolerance. Proc Natl Acad Sci U S A. 2019 11 19; 116(47):23682-23690.
    View in: PubMed
    Score: 0.119
  16. Desensitization in the Era of Precision Medicine: Moving From the Bench to Bedside. Transplantation. 2019 08; 103(8):1574-1581.
    View in: PubMed
    Score: 0.117
  17. New insights into the development of B cell responses: Implications for solid organ transplantation. Hum Immunol. 2019 Jun; 80(6):378-384.
    View in: PubMed
    Score: 0.110
  18. Transplantation tolerance: don't forget about the B cells. Clin Exp Immunol. 2017 08; 189(2):171-180.
    View in: PubMed
    Score: 0.099
  19. Tracing Donor-MHC Class II Reactive B cells in Mouse Cardiac Transplantation: Delayed CTLA4-Ig Treatment Prevents Memory Alloreactive B-Cell Generation. Transplantation. 2016 08; 100(8):1683-91.
    View in: PubMed
    Score: 0.095
  20. Delayed Cytotoxic T Lymphocyte-Associated Protein 4-Immunoglobulin Treatment Reverses Ongoing Alloantibody Responses and Rescues Allografts From Acute Rejection. Am J Transplant. 2016 08; 16(8):2312-23.
    View in: PubMed
    Score: 0.093
  21. Spontaneous restoration of transplantation tolerance after acute rejection. Nat Commun. 2015 Jul 07; 6:7566.
    View in: PubMed
    Score: 0.088
  22. Memory B cells in transplantation. Transplantation. 2015 Jan; 99(1):21-8.
    View in: PubMed
    Score: 0.085
  23. Transplantation tolerance and its outcome during infections and inflammation. Immunol Rev. 2014 Mar; 258(1):80-101.
    View in: PubMed
    Score: 0.081
  24. Microbes and allogeneic transplantation. Transplantation. 2014 Jan 15; 97(1):5-11.
    View in: PubMed
    Score: 0.080
  25. IL-6 induced by Staphylococcus aureus infection prevents the induction of skin allograft acceptance in mice. Am J Transplant. 2011 May; 11(5):936-46.
    View in: PubMed
    Score: 0.066
  26. Alloantibodies prevent the induction of transplantation tolerance by enhancing alloreactive T cell priming. J Immunol. 2011 Jan 01; 186(1):214-21.
    View in: PubMed
    Score: 0.064
  27. Memory alloreactive B cells and alloantibodies prevent anti-CD154-mediated allograft acceptance. J Immunol. 2009 Feb 01; 182(3):1314-24.
    View in: PubMed
    Score: 0.057
  28. Low-affinity CD8+ T cells provide interclonal help to high-affinity CD8+ T cells to augment alloimmunity. Am J Transplant. 2024 Jun; 24(6):933-943.
    View in: PubMed
    Score: 0.040
  29. Allograft tolerance induced by intact active bone co-transplantation and anti-CD40L monoclonal antibody therapy. Transplantation. 2002 Aug 15; 74(3):345-54.
    View in: PubMed
    Score: 0.036
  30. Oral alloantigen exposure promotes donor-specific tolerance in a mouse model of minor-mismatched skin transplantation. Am J Transplant. 2022 10; 22(10):2348-2359.
    View in: PubMed
    Score: 0.036
  31. Combination of antilymphocyte globulin and leflunomide leads to superior grafts. Transplant Proc. 2001 Feb-Mar; 33(1-2):569.
    View in: PubMed
    Score: 0.033
  32. Induction of species-specific host accommodation in the hamster-to-rat xenotransplantation model. J Immunol. 1998 Aug 15; 161(4):2044-51.
    View in: PubMed
    Score: 0.027
  33. Effect of leflunomide and cyclosporine on concordant xenogeneic islet transplantation in streptozotocin-induced and autoimmune diabetic mice. Transplant Proc. 1997 Jun; 29(4):2155.
    View in: PubMed
    Score: 0.025
  34. Prolongation of rat islet allograft survival by the immunosuppressive agent leflunomide. Transplantation. 1997 Mar 15; 63(5):711-6.
    View in: PubMed
    Score: 0.025
  35. The composition of the microbiota modulates allograft rejection. J Clin Invest. 2016 07 01; 126(7):2736-44.
    View in: PubMed
    Score: 0.024
  36. High-Fat Diet-Induced Obesity Enhances Allograft Rejection. Transplantation. 2016 05; 100(5):1015-21.
    View in: PubMed
    Score: 0.023
  37. Inactivation of Kupffer cells after prolonged donor fasting improves viability of transplanted hepatic allografts. Hepatology. 1995 Oct; 22(4 Pt 1):1236-42.
    View in: PubMed
    Score: 0.022
  38. Improved viability of hepatic allografts from fasted donors is associated with decreased peripheral TNF activity. J Surg Res. 1995 Mar; 58(3):337-43.
    View in: PubMed
    Score: 0.022
  39. Effect of leflunomide in control of acute rejection in hamster-to-rat cardiac xenografts. Transplant Proc. 1994 Jun; 26(3):1263-5.
    View in: PubMed
    Score: 0.020
  40. Leflunomide immunosuppression in rat small intestinal transplantation. Transplant Proc. 1994 Jun; 26(3):1599-600.
    View in: PubMed
    Score: 0.020
  41. Allograft ultraviolet-B irradiation in rat small intestinal transplantation. Transplant Proc. 1994 Jun; 26(3):1624-5.
    View in: PubMed
    Score: 0.020
  42. Leflunomide in experimental transplantation. Control of rejection and alloantibody production, reversal of acute rejection, and interaction with cyclosporine. Transplantation. 1994 Apr 27; 57(8):1223-31.
    View in: PubMed
    Score: 0.020
  43. Immunosuppressive effects of leflunomide in a cardiac allograft model. Transplant Proc. 1993 Feb; 25(1 Pt 1):745-6.
    View in: PubMed
    Score: 0.019
  44. Skin graft survival in genetically identical cloned pigs. Cloning Stem Cells. 2003; 5(2):117-21.
    View in: PubMed
    Score: 0.009
  45. FK506 treatment in combination with leflunomide in hamster-to-rat heart and liver xenograft transplantation. Transplantation. 1998 Oct 15; 66(7):832-7.
    View in: PubMed
    Score: 0.007
  46. Protective effect of ischemic preconditioning on liver preservation-reperfusion injury in rats. Transplantation. 1998 Jul 27; 66(2):152-7.
    View in: PubMed
    Score: 0.007
  47. Anti-CD4 therapy in combined heart-kidney, heart-liver, and heart-small bowel allotransplants in high-responder rats. Transplantation. 1998 Jul 15; 66(1):1-5.
    View in: PubMed
    Score: 0.007
  48. Leflunomide-based immunosuppression for porcine islet xenotransplantation. Transplant Proc. 1998 Mar; 30(2):515.
    View in: PubMed
    Score: 0.007
  49. Effect of anti-CD4 monoclonal antibody combined with human CTLA4Ig on the survival of hamster liver and heart xenografts in Lewis rats. Transplantation. 1997 Jul 27; 64(2):317-21.
    View in: PubMed
    Score: 0.006
  50. Successful xenotransplantation of adult porcine islets in NOD and BALB/c mice with leflunomide and cyclosporine. Transplant Proc. 1997 Jun; 29(4):2166-7.
    View in: PubMed
    Score: 0.006
  51. Gene gun-mediated gene transfer and expression in rat islets. Transplant Proc. 1997 Jun; 29(4):2209-10.
    View in: PubMed
    Score: 0.006
  52. Granulocyte colony-stimulating factor immunomodulation in the rat cardiac transplantation model. Transplantation. 1996 Apr 15; 61(7):1122-5.
    View in: PubMed
    Score: 0.006
  53. Leflunomide controls rejection in hamster to rat cardiac xenografts. Transplantation. 1994 Oct 15; 58(7):828-34.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.